The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> Analyst Interviews >> March 15, 2019

Early-Stage Biotechs to Release Clinical Data Readouts in 2019

Raja, Kumaraguru
Kumaraguru Raja, Ph.D., MBA, is Director, Senior Biotechnology Analyst at Brookline Capital Markets. Before coming to Brookline Capital, Dr. Raja was Vice President, Biotechnology Research at Noble Life Science Partners. Dr. Raja has significant experience as an equity analyst in the health care industry with a focus on the biotechnology sector. Previously, he was a senior associate analyst for over five years on the Citi Research biotechnology team that has been continuously ranked highly for biotechnology in the All-America Institutional Investor survey. Dr. Raja’s expertise includes bottom-up scientific, financial analysis on companies across therapeutic areas and spectrum of market capitalizations. Dr. Raja has strong quantitative, scientific background with in-depth biotechnology and health care industry knowledge leveraged to identify compelling investment opportunities. Dr. Raja has substantial experience working with leading U.S. institutional clients. He has deep knowledge of the health care industry, including drug development, intellectual property, FDA and EMA regulations, reimbursement coverage and clinical science. Dr. Raja conducted postdoctoral research at Mayo Clinic to understand the epigenetic causes of cancer and at Los Angeles Biomedical Research Institute to elucidate the molecular mechanisms concerning the role of human bone marrow stem cells in normal and leukemic hematopoiesis. He received his Ph.D. in biological sciences from Bowling Green State University and MBA from University of California, San Diego. Profile
Word count: 2,010

TWST: What do you cover currently, and could you express a few sentiments about it overall?

Dr. Raja: I mostly cover early-stage biotechnology

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
AI Opportunities Expand to Industrial, Utilities and Energy Sectors
India Fund Manager Expects Discretionary Spending to Grow
Inefficiency in Ex-US Markets Creates Opportunity to Buy at a Discount
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy